DOI: 10.12890/2025_005872
From crisis to recovery: life-saving IgM-enriched immunoglobulin rescue therapy in severe CAP and refractory post-partum septic shock – a dramatic 24-hour turnaround
Authors
drsewafie@hotmail.com
Keywords
Sepsis, community-acquired pneumonia, postpartum sepsis, IgM-enriched immunoglobulin, rescue therapyAbstract
Background: Septic shock in the postpartum period is a life-threatening condition associated with significant mortality. The physiological changes of pregnancy and the puerperium often complicate diagnosis and treatment, making timely, effective intervention critical. When conventional antimicrobial therapy fails, alternative therapeutic strategies become essential. Recent systematic reviews have highlighted the potential benefits of IgM-enriched immunoglobulin in reducing mortality among sepsis patients.
Case description: We report the case of a 25-year-old previously healthy woman who developed severe septic shock following caesarean section delivery. The clinical picture was complicated by influenza A pneumonia and a urinary tract infection caused by Escherichia coli. Despite administration of broad-spectrum standard antimicrobial treatments, the patient exhibited rapid clinical deterioration, with escalating vasopressor requirements and severe hyperinflammation. Biomarkers were profoundly elevated, including a procalcitonin level of 386.2 ng/ml and a C-reactive protein of 424 mg/l. Given the failure of standard therapy and the critical condition, IgM-enriched immunoglobulin (Pentaglobin®) was administered as a rescue therapy. Within 24 hours of infusion, the patient demonstrated significant clinical and biochemical improvement, with normalisation of vital signs, reduced inflammatory markers and early weaning from vasopressors. She achieved full recovery and rapid hospital discharge.
Conclusion: This case highlights the potential life-saving role of IgM-enriched immunoglobulin and its potential therapeutic value in managing refractory postpartum sepsis and severe community-acquired pneumonia (CAP). While promising, the timing, dosage and patient selection for this therapy require further clinical investigation, particularly in obstetric populations.
References
- Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama 2016;315:801–810. doi: 10.1001/jama.2016.0287
- Bermejo Martín JF, Rodriguez Fernandez A, Herrán Monge R, Andaluz Ojeda D, Muriel-Bombín A, Merino P, et al. GRECIA Group (Grupo de Estudios y Análisis en Cuidados Intensivos). Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis. J Intern Med 2014;276:404–412. doi: 10.1111/joim.12265
- Nierhaus A, Berlot G, Kindgen-Milles D, Müller E, Girardis M. Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis. Ann Intensive Care 2020;10:132. doi: 10.1186/s13613-020-00740-1
- Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org; Plante LA, Pacheco LD, Louis JM. SMFM Consult Series #47: Sepsis during pregnancy and the puerperium. Am J Obstet Gynecol 2019;220:B2–B10. doi: 10.1016/j.ajog.2019.01.216
- Cui J, Wei X, Lv H, Li Y, Li P, Chen Z, et al. The clinical efficacy of intravenous IgM-enriched immunoglobulin (Pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis. Ann Intensive Care 2019;9:27. doi: 10.1186/s13613-019-0501-3
- Pan B, Sun P, Pei R, Lin F, Cao H. Efficacy of IVIG therapy for patients with sepsis: a systematic review and meta-analysis. J Transl Med 2023;21:765. doi: 10.1186/s12967-023-04592-8
- Tugrul S, Ozcan PE, Akinci O, Seyhun Y, Cagatay A, Cakar N, et al. The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]. Crit Care 2002;6:357–362. doi: 10.1186/cc1523
- Giamarellos-Bourboulis EJ, Tziolos N, Routsi C, Katsenos C, Tsangaris I, Pneumatikos I, et al. Hellenic Sepsis Study Group. Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins. Clin Microbiol Infect 2016;22:499–506. doi: 10.1016/j.cmi.2016.01.021
- Dinleyici EC, Frey G, Kola E, Wippermann U, Bauhofer A, Staus A, et al. Clinical efficacy of IgM-enriched immunoglobulin as adjunctive therapy in neonatal and pediatric sepsis: a systematic review and meta-analysis. Front Pediatr 2023;11:1239014. doi: 10.3389/fped.2023.1239014
- Welte T, Dellinger RP, Ebelt H, Ferrer M, Opal SM, Singer M, et al. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study). Intensive Care Med 2018;44:438–448. doi: 10.1007/s00134-018-5143-7
